Cytarabine (Pfizer Laboratories Div Pfizer Inc.)


Welcome to the PulseAid listing for the Cytarabine drug offered from Pfizer Laboratories Div Pfizer Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Pfizer Laboratories Div Pfizer Inc.
NON-PROPRIETARY NAME: Cytarabine
SUBSTANCE NAME: CYTARABINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
ROUTE: INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2011-12-14
END MARKETING DATE: 0000-00-00


Cytarabine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCytarabine from Pfizer Laboratories Div Pfizer Inc.
LABELER NAME: Pfizer Laboratories Div Pfizer Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/5mL)
START MARKETING DATE: 2011-12-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0069-0152_c296d15c-df78-49e7-b55a-ff070822fdf9
PRODUCT NDC: 0069-0152
APPLICATION NUMBER: ANDA200915

Other CYTARABINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCCytarabine
Hospira Worldwide, Inc.Cytarabine
Hospira, Inc.CYTARABINE
Mylan Institutional LLCCytarabine
Pfizer Laboratories Div Pfizer Inc.Cytarabine
Sigma-Tau Pharmaceuticals, Inc.DepoCyt